Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients.

Reátegui-Sokolova C, Rodríguez-Bellido Z, Gamboa-Cárdenas RV, Medina M, Zevallos F, Pimentel-Quiroz VR, Elera-Fitzcarrald C, Cucho-Venegas M, Pastor-Asurza CA, Perich-Campos R, Alarcón GS, Ugarte-Gil MF.

Lupus. 2019 Oct;28(11):1344-1349. doi: 10.1177/0961203319876998. Epub 2019 Sep 24.

PMID:
31551028
2.

Correction to: Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort.

Gamboa-Cárdenas RV, Ugarte-Gil MF, Massardo L, Sacnun MP, Saurit V, Cardiel MH, Soriano ER, Pisoni C, Galarza-Maldonado CM, Rios C, Radominski SC, Castelar-Pinheiro GDR, Bianchi WA, Appenzeller S, da Silveira IG, de Freitas Zerbini CA, Caballero-Uribe CV, Rojas-Villarraga A, Guibert-Toledano M, Ballesteros F, Montufar R, Vázquez-Mellado J, Esquivel-Valerio J, De La Torre IG, Barile-Fabris LA, Palezuelos FI, Andrade-Ortega L, Monge P, Teijeiro R, Achurra-Castillo ÁF, Esteva Spinetti MH, Alarcón GS, Pons-Estel BA.

Clin Rheumatol. 2019 Oct;38(10):2963-2964. doi: 10.1007/s10067-019-04742-8.

PMID:
31432337
3.

Lupus: the new epidemic.

Ugarte-Gil MF, González LA, Alarcón GS.

Lupus. 2019 Aug;28(9):1031-1050. doi: 10.1177/0961203319860907. Epub 2019 Jul 12.

PMID:
31299878
4.

Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.

Pimentel-Quiroz VR, Ugarte-Gil MF, Harvey GB, Wojdyla D, Pons-Estel GJ, Quintana R, Esposto A, García MA, Catoggio LJ, Cardiel MH, Barile LA, Amigo MC, Sato EI, Bonfa E, Borba E, Lavras Costallat LT, Neira OJ, Massardo L, Guibert-Toledano M, Chacón-Díaz R, Alarcón GS, Pons-Estel BA.

Lupus. 2019 Aug;28(9):1101-1110. doi: 10.1177/0961203319860579. Epub 2019 Jul 10.

PMID:
31291843
5.

Time in remission and low disease activity state (LDAS) are associated with a better quality of life in patients with systemic lupus erythematosus: results from LUMINA (LXXIX), a multiethnic, multicentre US cohort.

Ugarte-Gil MF, Pons-Estel GJ, Vila LM, McGwin G, Alarcón GS.

RMD Open. 2019 May 23;5(1):e000955. doi: 10.1136/rmdopen-2019-000955. eCollection 2019.

6.

Low Disease Activity State/Remission Predicts a Better Health-Related Quality of Life in Systemic Lupus Erythematosus Patients.

Ugarte-Gil MF, Gamboa-Cárdenas RV, Reátegui-Sokolova C, Medina-Chinchón M, Zevallos F, Elera-Fitzcarrald C, Pimentel-Quiroz V, Cucho-Venegas JM, Rodríguez-Bellido Z, Pastor-Asurza CA, Alarcón GS, Perich-Campos R.

Arthritis Care Res (Hoboken). 2019 Jun 14. doi: 10.1002/acr.24009. [Epub ahead of print]

PMID:
31199590
7.

Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort.

Gamboa-Cárdenas RV, Ugarte-Gil MF, Loreto M, Sacnun MP, Saurit V, Cardiel MH, Soriano ER, Pisoni C, Galarza-Maldonado CM, Rios C, Radominski SC, Castelar-Pinheiro GDR, Bianchi WA, Appenzeller S, da Silveira IG, de Freitas Zerbini CA, Caballero-Uribe CV, Rojas-Villarraga A, Guibert-Toledano M, Ballesteros F, Montufar R, Vázquez-Mellado J, Esquivel-Valerio J, De La Torre IG, Barile-Fabris LA, Palezuelos FI, Andrade-Ortega L, Monge P, Teijeiro R, Achurra-Castillo ÁF, Esteva Spinetti MH, Alarcón GS, Pons-Estel BA.

Clin Rheumatol. 2019 Oct;38(10):2737-2746. doi: 10.1007/s10067-019-04618-x. Epub 2019 Jun 3. Erratum in: Clin Rheumatol. 2019 Aug 20;:.

PMID:
31161486
8.

Medical Scientific Publications From Latin America: A Commentary.

Ugarte-Gil MF, Alarcón GS.

J Clin Rheumatol. 2019 Jun;25(4):157-158. doi: 10.1097/RHU.0000000000000907. No abstract available.

PMID:
31125322
9.

Correction to: Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort.

Zeña-Huancas PA, Iparraguirre-López H, Gamboa-Cárdenas RV, Reátegui-Sokolova C, Zevallos-Miranda F, Medina-Chinchon M, Pimentel-Quiroz VR, Elera-Fitzcarrald C, Sarmiento-Velasquez O, Cucho-Venegas JM, Alfaro-Lozano JL, Rodríguez-Bellido ZJ, Pastor-Asurza CA, Perich-Campos RA, Alarcón GS, Ugarte-Gil MF.

Clin Rheumatol. 2019 Jun;38(6):1799. doi: 10.1007/s10067-019-04558-6.

PMID:
31037457
10.

Erratum corrige: "Peripheral CD4+CD28null T-cells as predictors of damage in systemic lupus erythematosus patients". M.F. Ugarte-Gil et al.

Ugarte-Gil MF, Sánchez-Zúñiga C, Gamboa-Cardenas RV, Aliaga-Zamudio M, Zevallos F, Mosqueira-Riveros A, Medina-Chinchón M, Tineo-Pozo G, Elera-Fitzcarrald C, Pimentel-Quiroz V, Sarmiento-Velasquez O, Reátegui-Sokolova C, Cucho-Venegas JM, Alfaro-Lozano J, Rodriguez-Bellido Z, Pastor-Asurza CA, Alarcón GS, Perich-Campos R.

Clin Exp Rheumatol. 2019 Mar-Apr;37(2):345. Epub 2019 Mar 19. No abstract available.

11.

Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Quintana R, Gómez-Puerta JA, Catoggio LJ, Alvarellos A, Saurit V, Borba E, Sato E, Costallat L, Da Silva NA, Iglesias-Gamarra A, Neira O, Reyes-Llerena G, Cardiel MH, Amigo MC, Acevedo-Vásquez E, Esteva-Spinetti MH, Alarcón GS, Pons-Estel BA.

J Rheumatol. 2019 Oct;46(10):1299-1308. doi: 10.3899/jrheum.180433. Epub 2019 Mar 1.

PMID:
30824636
12.

Gorham-Stout Syndrome: A Phantom Bone Disease Treated With Bisphosphonates.

Elera-Fitzcarrald C, Ugarte-Gil MF.

J Clin Rheumatol. 2019 Feb 19. doi: 10.1097/RHU.0000000000001009. [Epub ahead of print] No abstract available.

PMID:
30801337
13.

Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort.

Alarcón GS, Ugarte-Gil MF, Pons-Estel G, Vilá LM, Reveille JD, McGwin G Jr.

Lupus. 2019 Mar;28(3):423-426. doi: 10.1177/0961203319826693. Epub 2019 Jan 24.

PMID:
30678605
14.

Genetics and genomics in Peru: Clinical and research perspective.

Guio H, Poterico JA, Levano KS, Cornejo-Olivas M, Mazzetti P, Manassero-Morales G, Ugarte-Gil MF, Acevedo-Vásquez E, Dueñas-Roque M, Piscoya A, Fujita R, Sanchez C, Casavilca-Zambrano S, Jaramillo-Valverde L, Sullcahuaman-Allende Y, Iglesias-Pedraz JM, Abarca-Barriga H.

Mol Genet Genomic Med. 2018 Nov;6(6):873-886. doi: 10.1002/mgg3.533. Review.

15.

Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort.

Zeña-Huancas PA, Iparraguirre-López H, Gamboa-Cárdenas RV, Reátegui-Sokolova C, Zevallos-Miranda F, Medina-Chinchon M, Pimentel-Quiroz VR, Elera-Fitzcarrald C, Sarmiento-Velasquez O, Cucho-Venegas JM, Alfaro-Lozano JL, Rodríguez-Bellido ZJ, Pastor-Asurza CA, Perich-Campos RA, Alarcón GS, Ugarte-Gil MF.

Clin Rheumatol. 2019 Apr;38(4):1139-1146. doi: 10.1007/s10067-018-4389-3. Epub 2018 Dec 12. Erratum in: Clin Rheumatol. 2019 Apr 29;:.

PMID:
30539353
16.

A Practical Roadmap for Writing of Medical Scientific Publications.

Ugarte-Gil MF, Alarcón GS.

J Clin Rheumatol. 2019 Oct;25(7):314-317. doi: 10.1097/RHU.0000000000000944.

PMID:
30520825
17.

Factors affecting quality of life in patients with systemic lupus erythematosus: important considerations and potential interventions.

Elera-Fitzcarrald C, Fuentes A, González LA, Burgos PI, Alarcón GS, Ugarte-Gil MF.

Expert Rev Clin Immunol. 2018 Nov;14(11):915-931. doi: 10.1080/1744666X.2018.1529566. Epub 2018 Oct 8. Review.

PMID:
30266076
18.

Is Low Disease Activity Sufficient as a Target in Systemic Lupus Erythematosus? Comment on the Article by Petri et al.

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Pons-Estel BA, Alarcón GS.

Arthritis Rheumatol. 2018 Dec;70(12):2098-2099. doi: 10.1002/art.40694. Epub 2018 Sep 24. No abstract available.

PMID:
30120903
19.

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR).

Pons-Estel BA, Bonfa E, Soriano ER, Cardiel MH, Izcovich A, Popoff F, Criniti JM, Vásquez G, Massardo L, Duarte M, Barile-Fabris LA, García MA, Amigo MC, Espada G, Catoggio LJ, Sato EI, Levy RA, Acevedo Vásquez EM, Chacón-Díaz R, Galarza-Maldonado CM, Iglesias Gamarra AJ, Molina JF, Neira O, Silva CA, Vargas Peña A, Gómez-Puerta JA, Scolnik M, Pons-Estel GJ, Ugolini-Lopes MR, Savio V, Drenkard C, Alvarellos AJ, Ugarte-Gil MF, Babini A, Cavalcanti A, Cardoso Linhares FA, Haye Salinas MJ, Fuentes-Silva YJ, Montandon de Oliveira E Silva AC, Eraso Garnica RM, Herrera Uribe S, Gómez-Martín D, Robaina Sevrini R, Quintana RM, Gordon S, Fragoso-Loyo H, Rosario V, Saurit V, Appenzeller S, Dos Reis Neto ET, Cieza J, González Naranjo LA, González Bello YC, Collado MV, Sarano J, Retamozo S, Sattler ME, Gamboa-Cárdenas RV, Cairoli E, Conti SM, Amezcua-Guerra LM, Silveira LH, Borba EF, Pera MA, Alba Moreyra PB, Arturi V, Berbotto GA, Gerling C, Gobbi CA, Gervasoni VL, Scherbarth HR, Brenol JCT, Cavalcanti F, Costallat LTL, Da Silva NA, Monticielo OA, Seguro LPC, Xavier RM, Llanos C, Montúfar Guardado RA, Garcia de la Torre I, Pineda C, Portela Hernández M, Danza A, Guibert-Toledano M, Reyes GL, Acosta Colman MI, Aquino AM, Mora-Trujillo CS, Muñoz-Louis R, García Valladares I, Orozco MC, Burgos PI, Betancur GV, Alarcón GS; Grupo Latino Americano de Estudio del Lupus (GLADEL) and Pan-American League of Associations of Rheumatology (PANLAR).

Ann Rheum Dis. 2018 Nov;77(11):1549-1557. doi: 10.1136/annrheumdis-2018-213512. Epub 2018 Jul 25.

20.

A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients.

Pons-Estel GJ, Quintana R, Alarcón GS, Sacnún M, Ugarte-Gil MF, Pons-Estel BA; GLADEL.

Lupus. 2018 Sep;27(10):1753-1754. doi: 10.1177/0961203318776104. Epub 2018 May 15. No abstract available.

PMID:
29764291
21.

Peripheral CD4+CD28null T-cells as predictors of damage in systemic lupus erythematosus patients.

Ugarte-Gil MF, Sánchez-Zúñiga C, Gamboa-Cardenas RV, Aliaga-Zamudio M, Zevallos F, Mosqueira-Riveros A, Medina-Chinchón M, Tineo-Pozo G, Elera-Fitzcarrald C, Pimentel-Quiroz V, Sarmiento-Velasquez O, Reátegui-Sokolova C, Cucho-Venegas JM, Alfaro-Lozano J, Rodriguez-Bellido Z, Pastor-Asurza C, Alarcón GS, Perich-Campos R.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6):1008-1013. Epub 2018 May 8. Erratum in: Clin Exp Rheumatol. 2019 Mar-Apr;37(2):345.

PMID:
29745892
22.

Remission or low disease activity as a target in systemic lupus erythematosus.

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Pons-Estel BA, Alarcón GS; GLADEL.

Ann Rheum Dis. 2019 Jan;78(1):e3. doi: 10.1136/annrheumdis-2017-212876. Epub 2018 Jan 8. No abstract available.

PMID:
29311147
23.

Factors associated with health-related quality of life in Peruvian patients with systemic lupus erythematosus.

Elera-Fitzcarrald C, Alva M, Gamboa-Cardenas R, Mora-Trujillo CS, Zevallos F, García-Poma A, Medina M, Rodriguez-Bellido Z, Perich-Campos RA, Pastor-Asurza CA, Segami MI, Ugarte-Gil MF.

Lupus. 2018 May;27(6):913-919. doi: 10.1177/0961203317751062. Epub 2018 Jan 4.

PMID:
29301472
24.

Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Catoggio LJ, Drenkard C, Sarano J, Berbotto GA, Borba EF, Sato EI, Tavares Brenol JC, Uribe O, Ramirez Gómez LA, Guibert-Toledano M, Massardo L, Cardiel MH, Silveira LH, Chacón-Diaz R, Alarcón GS, Pons-Estel BA; GLADEL.

Ann Rheum Dis. 2017 Dec;76(12):2071-2074. doi: 10.1136/annrheumdis-2017-211814. Epub 2017 Sep 22.

PMID:
28939626
25.

Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.

Ugarte-Gil MF, Wojdyla D, Pastor-Asurza CA, Gamboa-Cárdenas RV, Acevedo-Vásquez EM, Catoggio LJ, García MA, Bonfá E, Sato EI, Massardo L, Pascual-Ramos V, Barile LA, Reyes-Llerena G, Iglesias-Gamarra A, Molina-Restrepo JF, Chacón-Díaz R, Alarcón GS, Pons-Estel BA.

Lupus. 2018 Apr;27(4):536-544. doi: 10.1177/0961203317728810. Epub 2017 Aug 31.

PMID:
28857715
26.

Defining Quality of Rheumatologic Care: Peru.

Reátegui-Sokolova C, Pimentel-Quiroz VR, Elera-Fitzcarrald C, Ugarte-Gil MF, Calvo A, Alarcón GS.

J Clin Rheumatol. 2017 Jun;23(4):212-214. doi: 10.1097/RHU.0000000000000527. No abstract available.

PMID:
28538276
27.

Epidemiology of systemic lupus erythematosus.

Pons-Estel GJ, Ugarte-Gil MF, Alarcón GS.

Expert Rev Clin Immunol. 2017 Aug;13(8):799-814. doi: 10.1080/1744666X.2017.1327352. Epub 2017 May 16. Review.

PMID:
28471259
28.

Factors predictive of high disease activity early in the course of SLE in patients from a Latin-American cohort.

Pimentel-Quiroz VR, Ugarte-Gil MF, Pons-Estel GJ, Soriano ER, Saurit V, Sato EI, Lavras Costallat LT, Molina JF, Iglesias-Gamarra A, Reyes-Llerena G, Neira OJ, Barile LA, Silveira LH, Segami MI, Chacón-Díaz R, Wojdyla D, Alarcón GS, Pons-Estel BA.

Semin Arthritis Rheum. 2017 Oct;47(2):199-203. doi: 10.1016/j.semarthrit.2017.01.012. Epub 2017 Feb 2.

PMID:
28291583
29.

Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients.

Reátegui-Sokolova C, Ugarte-Gil MF, Gamboa-Cárdenas RV, Zevallos F, Cucho-Venegas JM, Alfaro-Lozano JL, Medina M, Rodriguez-Bellido Z, Pastor-Asurza CA, Alarcón GS, Perich-Campos RA.

Clin Rheumatol. 2017 Apr;36(4):845-852. doi: 10.1007/s10067-017-3538-4. Epub 2017 Jan 18.

PMID:
28101832
30.

Prolactin levels are associated with a pro-inflammatory body mass distribution among women with systemic lupus erythematosus.

Elera-Fitzcarrald C, Ugarte-Gil MF, Gamboa-Cárdenas RV, Zevallos F, Medina M, Cucho-Venegas JM, Perich-Campos RA, Alfaro-Lozano JL, Rodriguez-Bellido Z, Alarcón GS, Pastor-Asurza CA.

Lupus. 2017 Jul;26(8):808-814. doi: 10.1177/0961203316678673. Epub 2016 Nov 16.

PMID:
27852933
31.

Factors associated with disease expression patterns in systemic lupus erythematosus patients: results from LUMINA (LXXVII), a multiethnic US cohort.

Ugarte-Gil MF, Pimentel-Quiroz VR, Vilá LM, Reveille JD, McGwin G Jr, Alarcón GS.

Lupus. 2017 May;26(6):650-655. doi: 10.1177/0961203316665710. Epub 2016 Aug 24.

PMID:
27558795
32.

Treat to target in systemic lupus erythematosus: a commentary.

Ugarte-Gil MF, Burgos PI, Alarcón GS.

Clin Rheumatol. 2016 Aug;35(8):1903-1907. doi: 10.1007/s10067-016-3346-2. Epub 2016 Jul 12. Review.

PMID:
27406378
33.

Abatacept for the treatment of systemic lupus erythematosus.

Pimentel-Quiroz VR, Ugarte-Gil MF, Alarcón GS.

Expert Opin Investig Drugs. 2016;25(4):493-9. doi: 10.1517/13543784.2016.1154943. Epub 2016 Mar 7. Review.

PMID:
26878310
34.

Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort.

González-Naranjo LA, Betancur OM, Alarcón GS, Ugarte-Gil MF, Jaramillo-Arroyave D, Wojdyla D, Pons-Estel GJ, Rondón-Herrera F, Vásquez-Duque GM, Quintana-López G, Da Silva NA, Tavares Brenol JC, Reyes-Llerena G, Pascual-Ramos V, Amigo MC, Massardo L, Alfaro-Lozano J, Segami MI, Esteva-Spinetti MH, Iglesias-Gamarra A, Pons-Estel BA.

Semin Arthritis Rheum. 2016 Jun;45(6):675-83. doi: 10.1016/j.semarthrit.2015.11.003. Epub 2015 Nov 12.

PMID:
26698222
35.

Disease features and outcomes in United States lupus patients of Hispanic origin and their Mestizo counterparts in Latin America: a commentary.

Ugarte-Gil MF, Pons-Estel GJ, Molineros J, Wojdyla D, McGwin G Jr, Nath SK, Pons-Estel BA, Alarcón-Riquelme M, Alarcón GS.

Rheumatology (Oxford). 2016 Mar;55(3):436-40. doi: 10.1093/rheumatology/kev280. Epub 2015 Sep 27.

36.

Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients.

Ugarte-Gil MF, Sánchez-Zúñiga C, Gamboa-Cárdenas RV, Aliaga-Zamudio M, Zevallos F, Tineo-Pozo G, Cucho-Venegas JM, Mosqueira-Riveros A, Medina M, Perich-Campos RA, Alfaro-Lozano JL, Rodriguez-Bellido Z, Alarcón GS, Pastor-Asurza CA.

Lupus. 2016 Mar;25(3):233-40. doi: 10.1177/0961203315604910. Epub 2015 Sep 18.

PMID:
26385221
37.

Incomplete Systemic Lupus Erythematosus: Early Diagnosis or Overdiagnosis?

Ugarte-Gil MF, Alarcón GS.

Arthritis Care Res (Hoboken). 2016 Mar;68(3):285-7. doi: 10.1002/acr.22663. No abstract available.

38.

Access to an optimal treatment. Current situation.

Ugarte-Gil MF, Silvestre AM, Pons-Estel BA.

Clin Rheumatol. 2015 Mar;34 Suppl 1:S59-66. doi: 10.1007/s10067-015-3018-7. Epub 2015 Jul 19. Review.

39.

Circulating naive and memory CD4+ T cells and metabolic syndrome in patients with systemic lupus erythematosus: data from a primarily Mestizo population.

Ugarte-Gil MF, Sánchez-Zúñiga C, Gamboa-Cárdenas RV, Aliaga-Zamudio M, Zevallos F, Tineo-Pozo G, Cucho-Venegas JM, Mosqueira-Riveros A, Perich-Campos RA, Alfaro-Lozano JL, Medina M, Rodríguez-Bellido Z, Alarcón GS, Pastor-Asurza CA.

Rheumatology (Oxford). 2015 Jul;54(7):1302-7. doi: 10.1093/rheumatology/keu434. Epub 2014 Nov 19.

PMID:
25413944
40.

Genetics of ANCA-associated Vasculitides.

Ugarte-Gil MF, Espinoza LR.

Curr Rheumatol Rep. 2014 Jul;16(7):428. doi: 10.1007/s11926-014-0428-5. Review.

PMID:
24828480
41.

High prolactin levels are independently associated with damage accrual in systemic lupus erythematosus patients.

Ugarte-Gil MF, Gamboa-Cárdenas RV, Zevallos F, Medina M, Cucho-Venegas JM, Perich-Campos RA, Alfaro-Lozano JL, Rodriguez-Bellido Z, Alarcón GS, Pastor-Asurza CA.

Lupus. 2014 Sep;23(10):969-74. doi: 10.1177/0961203314531083. Epub 2014 Apr 9.

PMID:
24718588
42.

Systemic lupus erythematosus: a therapeutic challenge for the XXI century.

Ugarte-Gil MF, Alarcón GS.

Clin Rheumatol. 2014 Apr;33(4):441-50. doi: 10.1007/s10067-014-2531-4. Epub 2014 Feb 28. Review.

PMID:
24577816
43.

The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort.

Ugarte-Gil MF, Acevedo-Vásquez E, Alarcón GS, Pastor-Asurza CA, Alfaro-Lozano JL, Cucho-Venegas JM, Segami MI, Wojdyla D, Soriano ER, Drenkard C, Brenol JC, de Oliveira e Silva Montandon AC, Costallat LT, Massardo L, Molina-Restrepo JF, Guibert-Toledano M, Silveira LH, Amigo MC, Barile-Fabris LA, Chacón-Díaz R, Esteva-Spinetti MH, Pons-Estel GJ, McGwin G Jr, Pons-Estel BA; GLADEL.

Ann Rheum Dis. 2015 Jun;74(6):1019-23. doi: 10.1136/annrheumdis-2013-204620. Epub 2014 Feb 13.

PMID:
24525909
44.

Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?

Berman H, Ugarte-Gil MF, Espinosa G, Tàssies D, Monteagudo J, Reverter JC, Cervera R.

Clin Exp Rheumatol. 2013 Nov-Dec;31(6):926-32. Epub 2013 Sep 30.

PMID:
24093662

Supplemental Content

Loading ...
Support Center